Welcome to iChemical.com!

In the below part, please select the country you want us to ship to: Please note that once you've selected a shipping country, all pricing information on our website will be automatically updated to include door-to-door shipping to the country you specified.

    OK
    Get Quote Login
    210345-86-1

    Catalog No. EBD312890

    CAS 210345-86-1

    Name (2R)-([amino]methyl)-3-methylbutanoic acid

    Get Quote
    Basic Information

    Synonyms: (2R)-([amino]methyl)-3-methylbutanoicacid (R)-3-amino-2-iso-propylpropanoicacid Butanoicacid,2-(aminomethyl)-3-methyl-,(2R)- (R)-2-(Aminomethyl)-3-methylbutanoicacid

    Molecular Formula: C6H13NO2

    Molecular Weight: 131.18

    Categories: Medicinal Chemistry > Pharmaceutical Intermediates > Chiral Intermediates Medicinal Chemistry > Biochemicals and Life Science Reagents > Amino Acids and Derivatives

    Product Description:
    (2R)-([amino]methyl)-3-methylbutanoic acid is a chiral, non-proteinogenic amino acid derivative. It features a β-amino acid structure with a methyl group at the 3-position and an aminomethyl group at the 2-position, where the stereocenter is in the (R)-configuration. This specific stereochemistry is crucial for its biological activity and utility in asymmetric synthesis. This compound is primarily utilized as a key chiral building block in pharmaceutical research and development. It serves as a critical intermediate in the synthesis of various bioactive molecules, particularly those targeting the central nervous system. Its structural motif is found in the synthesis of certain γ-aminobutyric acid (GABA) analogues and other neuroactive compounds. The (R)-enantiomer is specifically valued for constructing molecules with defined stereochemistry to interact with biological targets. As a β-amino acid derivative, it is also of interest in peptide mimetics and medicinal chemistry for creating novel peptidomimetic structures with enhanced metabolic stability. Its synthesis and application are subjects of research in developing new therapeutic agents.
    Physical Properties
    mg g kg ml l t